These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 3282354
21. The use of OKT3 for stubborn heart allograft rejection: an advance in clinical immunotherapy? Sweeney MS, Sinnott JT, Cullison JP, Weinstein SS. J Heart Transplant; 1987; 6(6):324-8. PubMed ID: 3320302 [Abstract] [Full Text] [Related]
29. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation. Hegewald MG, O'Connell JB, Renlund DG, Lee HR, Burton NA, Karwande SV, Jones KW, Lassetter JE, Bristow MR. J Heart Transplant; 1989; 8(4):303-9; discussion 309-10. PubMed ID: 2504897 [Abstract] [Full Text] [Related]
36. Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Thistlethwaite JR, Cosimi AB, Delmonico FL, Rubin RH, Talkoff-Rubin N, Nelson PW, Fang L, Russell PS. Transplantation; 1984 Dec; 38(6):695-701. PubMed ID: 6390834 [Abstract] [Full Text] [Related]
37. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. Ortho Multicenter Transplant Study Group. N Engl J Med; 1985 Aug 08; 313(6):337-42. PubMed ID: 2861567 [Abstract] [Full Text] [Related]
38. OKT3: First-dose safety and success. Cosimi AB. Nephron; 1987 Aug 08; 46 Suppl 1():12-8. PubMed ID: 3306421 [Abstract] [Full Text] [Related]